Cargando…
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study
Low HDL-cholesterol (<1.02 mmol/L [40 mg/dL] in men or <1.29 mmol/L [50 mg/dL] in women) occurs in about one-third of European patients with dyslipidemia and is an independent cardiovascular risk factor. Simultaneous correction of low HDL-cholesterol and high total-cholesterol and LDL-choleste...
Autores principales: | Vogt, Anja, Kassner, Ursula, Hostalek, Ulrike, Steinhagen-Thiessen, Elisabeth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291331/ https://www.ncbi.nlm.nih.gov/pubmed/17969377 |
Ejemplares similares
-
Statins Aggravate the Risk of Insulin Resistance in Human Muscle
por: Grunwald, Stefanie A., et al.
Publicado: (2022) -
Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study
por: Rosada, Adrian, et al.
Publicado: (2020) -
PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks
por: Hollstein, Tim, et al.
Publicado: (2020) -
Nautilus at Risk – Estimating Population Size and Demography of Nautilus pompilius
por: Dunstan, Andrew, et al.
Publicado: (2011) -
Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
por: Steinhagen-Thiessen, Elisabeth, et al.
Publicado: (2008)